213 related articles for article (PubMed ID: 16307453)
21. Organic Cation Transporter 2 Overexpression May Confer an Increased Risk of Gentamicin-Induced Nephrotoxicity.
Gai Z; Visentin M; Hiller C; Krajnc E; Li T; Zhen J; Kullak-Ublick GA
Antimicrob Agents Chemother; 2016 Sep; 60(9):5573-80. PubMed ID: 27401566
[TBL] [Abstract][Full Text] [Related]
22. Testosterone-independent down-regulation of Oct2 in the kidney medulla from a uranyl nitrate-induced rat model of acute renal failure: effects on distribution of a model organic cation, tetraethylammonium.
Shim WS; Park JH; Ahn SJ; Han L; Jin QR; Li H; Choi MK; Kim DD; Chung SJ; Shim CK
J Pharm Sci; 2009 Feb; 98(2):739-47. PubMed ID: 18484100
[TBL] [Abstract][Full Text] [Related]
23. Role of organic cation transporters in the renal handling of therapeutic agents and xenobiotics.
Wright SH
Toxicol Appl Pharmacol; 2005 May; 204(3):309-19. PubMed ID: 15845420
[TBL] [Abstract][Full Text] [Related]
24. Substrate-dependent ligand inhibition of the human organic cation transporter OCT2.
Belzer M; Morales M; Jagadish B; Mash EA; Wright SH
J Pharmacol Exp Ther; 2013 Aug; 346(2):300-10. PubMed ID: 23709117
[TBL] [Abstract][Full Text] [Related]
25. Expression of organic anion transporter 2 in the human kidney and its potential role in the tubular secretion of guanine-containing antiviral drugs.
Cheng Y; Vapurcuyan A; Shahidullah M; Aleksunes LM; Pelis RM
Drug Metab Dispos; 2012 Mar; 40(3):617-24. PubMed ID: 22190696
[TBL] [Abstract][Full Text] [Related]
26. Transport of asymmetric dimethylarginine (ADMA) by cationic amino acid transporter 2 (CAT2), organic cation transporter 2 (OCT2) and multidrug and toxin extrusion protein 1 (MATE1).
Strobel J; Müller F; Zolk O; Endreß B; König J; Fromm MF; Maas R
Amino Acids; 2013 Oct; 45(4):989-1002. PubMed ID: 23864433
[TBL] [Abstract][Full Text] [Related]
27. Interaction of beta-blockers with the renal uptake transporter OCT2.
Bachmakov I; Glaeser H; Endress B; Mörl F; König J; Fromm MF
Diabetes Obes Metab; 2009 Nov; 11(11):1080-3. PubMed ID: 19740083
[TBL] [Abstract][Full Text] [Related]
28. PharmGKB update: I. Genetic variants of the organic cation transporter 2 (OCT2, SLC22A2).
Leabman MK; Huang CC; Stryke D; Johns SJ; Kawamoto M; Ferrin TE; DeYoung J; Taylor TR; De La Cruz M; Herskowitz I; Giacomini KM
Pharmacol Rev; 2003 Sep; 55(3):399. PubMed ID: 12869664
[No Abstract] [Full Text] [Related]
29. The organic cation transporter OCT2 mediates the uptake of beta-adrenoceptor antagonists across the apical membrane of renal LLC-PK(1) cell monolayers.
Dudley AJ; Bleasby K; Brown CD
Br J Pharmacol; 2000 Sep; 131(1):71-9. PubMed ID: 10960071
[TBL] [Abstract][Full Text] [Related]
30. Polymorphisms in a human kidney xenobiotic transporter, OCT2, exhibit altered function.
Leabman MK; Huang CC; Kawamoto M; Johns SJ; Stryke D; Ferrin TE; DeYoung J; Taylor T; Clark AG; Herskowitz I; Giacomini KM;
Pharmacogenetics; 2002 Jul; 12(5):395-405. PubMed ID: 12142729
[TBL] [Abstract][Full Text] [Related]
31. Organic cation transporter-mediated renal secretion of ipratropium and tiotropium in rats and humans.
Nakanishi T; Haruta T; Shirasaka Y; Tamai I
Drug Metab Dispos; 2011 Jan; 39(1):117-22. PubMed ID: 20962061
[TBL] [Abstract][Full Text] [Related]
32. Physiological and pharmacokinetic roles of H+/organic cation antiporters (MATE/SLC47A).
Terada T; Inui K
Biochem Pharmacol; 2008 May; 75(9):1689-96. PubMed ID: 18262170
[TBL] [Abstract][Full Text] [Related]
33. The variant organic cation transporter 2 (OCT2)-T201M contribute to changes in insulin resistance in patients with type 2 diabetes treated with metformin.
Kashi Z; Masoumi P; Mahrooz A; Hashemi-Soteh MB; Bahar A; Alizadeh A
Diabetes Res Clin Pract; 2015 Apr; 108(1):78-83. PubMed ID: 25662675
[TBL] [Abstract][Full Text] [Related]
34. Effect of genetic variation in the organic cation transporter 2 on the renal elimination of metformin.
Chen Y; Li S; Brown C; Cheatham S; Castro RA; Leabman MK; Urban TJ; Chen L; Yee SW; Choi JH; Huang Y; Brett CM; Burchard EG; Giacomini KM
Pharmacogenet Genomics; 2009 Jul; 19(7):497-504. PubMed ID: 19483665
[TBL] [Abstract][Full Text] [Related]
35. The organic cation transporters rOCT1 and hOCT2 are inhibited by cGMP.
Schlatter E; Mönnich V; Cetinkaya I; Mehrens T; Ciarimboli G; Hirsch JR; Popp C; Koepsell H
J Membr Biol; 2002 Oct; 189(3):237-44. PubMed ID: 12395288
[TBL] [Abstract][Full Text] [Related]
36. Pharmacological and physiological functions of the polyspecific organic cation transporters: OCT1, 2, and 3 (SLC22A1-3).
Jonker JW; Schinkel AH
J Pharmacol Exp Ther; 2004 Jan; 308(1):2-9. PubMed ID: 14576340
[TBL] [Abstract][Full Text] [Related]
37. The Role of NF-kB in the Downregulation of Organic Cation Transporter 2 Expression and Renal Cation Secretion in Kidney Disease.
Han C; Zheng J; Wang F; Lu Q; Chen Q; Hu A; Visentin M; Kullak-Ublick GA; Gai Z; Chu L
Front Med (Lausanne); 2021; 8():800421. PubMed ID: 35059420
[TBL] [Abstract][Full Text] [Related]
38. Agmatine is efficiently transported by non-neuronal monoamine transporters extraneuronal monoamine transporter (EMT) and organic cation transporter 2 (OCT2).
Gründemann D; Hahne C; Berkels R; Schömig E
J Pharmacol Exp Ther; 2003 Feb; 304(2):810-7. PubMed ID: 12538837
[TBL] [Abstract][Full Text] [Related]
39. Substrate-Dependent Inhibition of the Human Organic Cation Transporter OCT2: A Comparison of Metformin with Experimental Substrates.
Hacker K; Maas R; Kornhuber J; Fromm MF; Zolk O
PLoS One; 2015; 10(9):e0136451. PubMed ID: 26327616
[TBL] [Abstract][Full Text] [Related]
40. Pharmacogenetics meets metabolomics: discovery of tryptophan as a new endogenous OCT2 substrate related to metformin disposition.
Song IS; Lee DY; Shin MH; Kim H; Ahn YG; Park I; Kim KH; Kind T; Shin JG; Fiehn O; Liu KH
PLoS One; 2012; 7(5):e36637. PubMed ID: 22590580
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
